Clinical Efficacy and Molecular Response Correlates of Adavosertib Combined With Cisplatin in mTNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined With Cisplatin in Patients With Metastatic Triple-Negative Breast Cancer (mTNBC)
Clin. Cancer Res 2020 Dec 23;[EPub Ahead of Print], TE Keenan, T Li, T Vallius, JL Guerriero, N Tayob, BS Kochupurakkal, J Davis, RG Pastorello, RK Tahara, L Anderson, J Conway, MX He, E Shannon, R Godin, PK Sorger, AD D'Andrea, B Overmoyer, EP Winer, EA Mittendorf, EM Van Allen, GI Shapiro, SM TolaneyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.